Button Elise B, Gavin Nicole C, Keogh Samantha J
Royal Brisbane and Women's Hospital.
Centre of Research Excellence in Nursing, Griffith University.
Oncol Nurs Forum. 2014 Jul 1;41(4):370-81. doi: 10.1188/14.ONF.370-381.
PURPOSE/OBJECTIVES: To quantify the characteristics of patients who die in the hospital from relapse after allogeneic hematopoietic stem cell transplantation (alloHSCT), explore palliative care integration and end-of-life (EOL) care, and benchmark standards of care.
Retrospective chart review cohort study; a cross-sectional survey design guided a national survey.
A chart review was conducted in a large tertiary hospital in Australia. The survey was distributed to leading alloHSCT centers in Australia and New Zealand.
The chart review sample group was patients in the hematology department who had received an alloHSCT, relapsed, and died in the hospital (N = 40). The survey sample group was the most advanced nurse involved in patient care at each facility (N = 14).
A quantitative data collection tool created for chart review, as well as patient notes written by the physician, were examined. The quantitative data collection tool was created for the survey, which was conducted via email or telephone.
The chart review measured patient demographics, palliative care integration, EOL care, and symptoms. Survey topics included services available, referrals to palliative care services, EOL discussions, and symptom management.
About half of the patients were seen by the palliative care service. Many patients experienced severe symptoms in the terminal phase. Survey participants felt EOL discussions were left until the terminal phase. Participants believed early palliative care integration was beneficial for patients and their family.
The chart review demonstrated late integration of palliative care and poor standards of EOL care. Survey results reiterated this and reflected that nurses are supportive of earlier integration of palliative care and improving EOL care.
Palliative care should be integrated earlier, and nursing roles have the potential to address unmet needs for these patients.
目的/目标:量化异基因造血干细胞移植(alloHSCT)后在医院因复发死亡的患者特征,探讨姑息治疗整合及临终(EOL)护理情况,并确定护理标准。
回顾性病历审查队列研究;横断面调查设计指导全国性调查。
在澳大利亚一家大型三级医院进行病历审查。调查分发至澳大利亚和新西兰的主要alloHSCT中心。
病历审查样本组为血液科接受alloHSCT、复发并在医院死亡的患者(N = 40)。调查样本组为各机构参与患者护理的最高级护士(N = 14)。
检查为病历审查创建的定量数据收集工具以及医生撰写的患者记录。为调查创建的定量数据收集工具通过电子邮件或电话进行调查。
病历审查测量患者人口统计学、姑息治疗整合、EOL护理及症状。调查主题包括可用服务、转介至姑息治疗服务、EOL讨论及症状管理。
约半数患者接受了姑息治疗服务。许多患者在终末期出现严重症状。调查参与者认为EOL讨论直到终末期才进行。参与者认为早期整合姑息治疗对患者及其家人有益。
病历审查显示姑息治疗整合较晚且EOL护理标准较差。调查结果重申了这一点,并反映护士支持更早整合姑息治疗及改善EOL护理。
应更早整合姑息治疗,护理角色有潜力满足这些患者未满足的需求。